Cushing Syndrome Workup
Initial Critical Step: Exclude Exogenous Glucocorticoids
Before any diagnostic testing, you must stop all exogenous glucocorticoid sources, as this is the most common cause of Cushing syndrome. 1
- Review all medications including oral steroids, inhalers, topical preparations, and injections to rule out exogenous use 1
- This step is non-negotiable and must precede all biochemical testing 2, 3
Step 1: Screening Tests to Confirm Hypercortisolism
Use one or more of the following first-line screening tests, which have sensitivities of 89-95%: 1
- 24-hour urinary free cortisol (UFC) 1, 2, 3
- Late-night salivary cortisol 1, 2, 3
- 1 mg overnight dexamethasone suppression test (DST) - cortisol should suppress to <1.8 μg/dL; failure to suppress indicates Cushing syndrome 1, 4
Important caveats for screening tests:
- Women on estrogen-containing contraceptives should not undergo dexamethasone suppression testing, as estrogen falsely elevates cortisol-binding globulin 1
- Severe obesity, uncontrolled diabetes, alcoholism, and depression can cause false positives (pseudo-Cushing's states) 4, 5
- CYP3A4 inducers can cause rapid dexamethasone metabolism and false positives 4
- Consider measuring dexamethasone levels during DST to confirm adequate absorption 4
Step 2: Measure Plasma ACTH to Determine Etiology
Once hypercortisolism is confirmed, measure morning (08:00-09:00h) plasma ACTH to distinguish ACTH-dependent from ACTH-independent disease. 1, 4, 2
ACTH Interpretation:
- ACTH >5 ng/L (detectable): Indicates ACTH-dependent Cushing syndrome 4
- ACTH >29 ng/L: 70% sensitivity and 100% specificity for Cushing disease (pituitary source) 4
- ACTH low or undetectable (<5 ng/L): Indicates ACTH-independent Cushing syndrome (adrenal source) 4
Technical considerations:
- ACTH must be collected in the morning (08:00-09:00h) when levels are highest 4
- Fasting is not required for ACTH measurement 4
- Patient must not be on exogenous steroids, which suppress ACTH 4
Step 3A: ACTH-Independent Cushing Syndrome (Low ACTH)
Proceed directly to adrenal imaging with CT or MRI to identify adrenal lesion(s). 1, 4
Imaging findings guide management:
- Benign adrenal adenoma: Unilateral cortisol-secreting tumor; treat with laparoscopic adrenalectomy 6, 4
- Adrenal carcinoma suspected when: Tumor >5 cm, irregular margins, inhomogeneity, or local invasion; requires open adrenalectomy with possible adjuvant therapy 6, 4
- Bilateral hyperplasia: Consider medical management or unilateral adrenalectomy 4
Step 3B: ACTH-Dependent Cushing Syndrome (Elevated ACTH)
Perform high-quality pituitary MRI with thin slices (3T preferred over 1.5T) to identify pituitary adenoma. 1, 4
MRI-based algorithm:
If pituitary adenoma ≥10 mm detected:
- Presume Cushing disease (pituitary source) and proceed to surgery 1, 4
- No further localization testing needed 4
If pituitary adenoma 6-9 mm detected:
- Consider CRH stimulation test for additional confirmation 1, 4
- May proceed to bilateral inferior petrosal sinus sampling (BIPSS) if equivocal 1
If no adenoma or lesion <6 mm:
- Proceed to BIPSS, which is the gold standard for distinguishing pituitary from ectopic ACTH sources 1, 4, 5
- MRI has only 63% sensitivity for ACTH-secreting microadenomas, which are often ≤2 mm 4
Step 4: Bilateral Inferior Petrosal Sinus Sampling (BIPSS)
BIPSS is the definitive test when pituitary MRI is normal or shows only small lesions (<6 mm), with 96-100% sensitivity and near 100% specificity. 4
BIPSS diagnostic criteria:
- Central-to-peripheral ACTH ratio ≥2:1 at baseline OR ≥3:1 after CRH or desmopressin stimulation confirms pituitary source 1, 4
- Measure prolactin simultaneously from petrosal sinuses to confirm adequate venous sampling 4
- Inter-petrosal sinus ACTH gradient ≥1.4 after stimulation may indicate tumor lateralization 4
Critical technical requirements:
- Must be performed at a specialized center by experienced interventional radiologist 1, 4
- Bilateral cannulation success rate should exceed 85% 4
- For cyclic Cushing disease, confirm active hypercortisolism immediately before BIPSS 4
- Stop medical therapy for Cushing disease before BIPSS to enable accurate interpretation 4
Step 5: If Ectopic ACTH Suspected
If BIPSS indicates ectopic source or clinical features suggest ectopic ACTH (very high UFC, profound hypokalemia):
- Perform whole-body CT (neck to pelvis, thin-slice) to locate ectopic ACTH-secreting tumor 1, 4
- Consider 68Ga-DOTATATE PET imaging for neuroendocrine tumors not visible on conventional imaging 4
- Thymic sources account for up to 2% of ectopic ACTH cases 6
Special Populations
Children over 6 years:
- Use same screening tests as adults (24-hour UFC, late-night salivary cortisol, or overnight 1 mg DST) 1
Children under 6 years:
Key Clinical Features to Support Diagnosis
Most specific features for Cushing syndrome include: 1, 6
- Buffalo hump, moon facies, supraclavicular and temporal fat pads 1, 7
- Purple abdominal striae (wide, >1 cm) 7
- Proximal muscle weakness 7
- Fragile skin with easy bruising 6
- Hypertension (70-90% of patients) 6
- Glucose abnormalities (>80% of patients) 6
- Centripetal fat distribution 1
Critical Pitfalls to Avoid
- Never proceed with diagnostic testing without first excluding exogenous glucocorticoid use 1, 2
- Do not perform DST in women on oral contraceptives - falsely elevated results 1
- Recognize pseudo-Cushing's states (obesity, depression, alcoholism) that mimic biochemical findings 4, 5
- Do not rely on MRI alone for ACTH-dependent disease - proceed to BIPSS when MRI is negative or shows only small lesions 4
- Ensure morning ACTH collection - afternoon levels are unreliable and don't correspond to diagnostic thresholds 4
- Average diagnostic delay is 3 years - maintain high clinical suspicion to reduce morbidity and mortality from cardiovascular events 1